Pfizer responds to its director’s claims about covid

Must read

David Hucks
David Hucks
David Hucks is a 12th generation descendant of the area we now call Myrtle Beach, S.C. David attended Coastal Carolina University and like most of his family, has never left the area. David is the lead journalist at

In 2020, covid was a health issue that affected every Horry County resident, business, and hospital concern. The virus caused local towns and businesses to close their doors and cost the American taxpayers billions in PPP reimbursements.

This week, MyrtleBeachSC News published an article where Jordan Tristan Walker, now former Pfizer Director of Research and Development, was caught on hidden camera admitting the firm continues to experiment with Covid variants increasing the potency of the virus ongoing.

Mr. Walker and all of his former employment associations with Pfizer have been scrubbed from all company listings, as well as, the entire internet.

Since deleted proof of Walker’s prominent role at Pfizer

However, even a small market news operation, like ours, was able to confirm his former employment with Pfizer.


We did reach out to Pfizer attempting to contact Albert Bourla, the President and CEO of Pfizer to confirm the statements made by Walker. Mr. Bourla was just returning from his engagement at the World Economic Forum.

While Bourla did not respond, Pfizer did put out a statement late yesterday p.m. There was no mention of Walker in Pfizer’s statement.


To be fair to Pfizer, we are including the company’s entire statement unedited and in full.

New York, N.Y., January 27, 2023 – Allegations have recently been made related to gain of function and directed evolution research at Pfizer and the company would like to set the record straight.  

In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research.  Working with collaborators, we have conducted research where the original SARS-CoV-2 virus has been used to express the spike protein from new variants of concern. This work is undertaken once a new variant of concern has been identified by public health authorities. This research provides a way for us to rapidly assess the ability of an existing vaccine to induce antibodies that neutralize a newly identified variant of concern. We then make this data available through peer reviewed scientific journals and use it as one of the steps to determine whether a vaccine update is required.   

In addition, to meet U.S. and global regulatory requirements for our oral treatment, PAXLOVID™, Pfizer undertakes in vitro work (e.g., in a laboratory culture dish) to identify potential resistance mutations to nirmatrelvir, one of PAXLOVID’s two components.  With a naturally evolving virus, it is important to routinely assess the activity of an antiviral.  Most of this work is conducted using computer simulations or mutations of the main protease–a non-infectious part of the virus.  In a limited number of cases when a full virus does not contain any known gain of function mutations, such virus may be engineered to enable the assessment of antiviral activity in cells. In addition, in vitro resistance selection experiments are undertaken in cells incubated with SARS-CoV-2 and nirmatrelvir in our secure Biosafety level 3 (BSL3) laboratory to assess whether the main protease can mutate to yield resistant strains of the virus.  It is important to note that these studies are required by U.S. and global regulators for all antiviral products and are carried out by many companies and academic institutions in the U.S. and around the world.

Fact-based information rooted in sound science is vitally important to overcoming the COVID-19 pandemic and Pfizer remains committed to transparency and helping alleviate the devastating burden of this disease.


After Pfizer’s statement was released, Gil Bashe, managing partner, chair global health and purpose at Finn Partners, said the following:

Sadly, this video is endemic to a society that needs immediate medical solutions to real public health threats. It opens the door to these sorts of news grabbers,” he said. “The media also relies on speed and speculation to attract audiences. This video — the yet unproven comments — are part of the public health risk we now all face. It’s the perfect storm of the desire for immediacy.”

On his corporate website, Bashe states: My career journey has included stints as an industry lobbyist, worldwide agency CEO, and part of one of the nation’s top private equity groups.


Alphabet owned, Youtube removed Walker’s statements from their platform. James O’Keefe (whose organization captured the sting operation) made statements about that which can be seen on video here:

Twitter chose to allow the former Pfizer employee’s video statements to remain fully intact.

This video has been viewed over 20 million times.


More articles

Latest article

- Advertisement -